Completed
Concomitant Dry Eye in Patients With Ocular Allergy: an Under Recognized and Poorly Managed Syndrome
What is being collected
Data Collection
Collected from today forward - ProspectiveWho is being recruted
Conjunctival Diseases+17
+ Conjunctivitis
+ Eye Diseases
Over 18 Years
+13 Eligibility Criteria
How is the trial designed
Case-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Observational
Study Start: August 2012
Summary
Principal SponsorSchwartz Laser Eye Center
Last updated: June 3, 2016
Sourced from a government-validated database.Claim as a partner
Study start date: August 1, 2012
Actual date on which the first participant was enrolled.Evaluating the percentage of patients that suffer from eye allergies and determining whether they also have dry eyes.
Principal SponsorSchwartz Laser Eye Center
Last updated: June 3, 2016
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
250 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Conjunctival DiseasesConjunctivitisEye DiseasesHypersensitivityHypersensitivity, ImmediateImmune System DiseasesLacrimal Apparatus DiseasesNervous System DiseasesNeurologic ManifestationsSensation DisordersSigns and SymptomsSkin DiseasesSkin ManifestationsPathological Conditions, Signs and SymptomsSkin and Connective Tissue DiseasesSomatosensory DisordersConjunctivitis, AllergicParesthesiaPruritusDry Eye Syndromes
Criteria
5 inclusion criteria required to participate
Ability to give informed consent
Diagnosis of allergic conjunctivitis
Males and females at least 18 years of age
Personal history of allergic disorders including but not limited to allergic conjunctivitis, allergic rhinitis, contact dermatitis and other eczema, and asthma
Show More Criteria
8 exclusion criteria prevent from participating
Active ocular or systemic infection
Current use of chemotherapeutic agents
History of ocular infection within past 6 months
Inability to give informed consent
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
CompletedOne Study Center